Willscot Mobile Mini Reports First Quarter 2024 Results 3-05-2024, 03:01

Mobile game Prize Kingdoms advances new free-to-earn gaming 19-02-2023, 23:36

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai 18-09-2024, 22:07